|
1
|
Ostrom QT, Gittleman H, Liao P, Rouse C,
Chen Y, Dowling J, Wolinsky Y, Kruchko C and Barnholtz-Sloan J:
CBTRUS statistical report: Primary brain and central nervous system
tumors diagnosed in the United States in 2007–2011. Neuro Oncol. 16
Suppl 4:iv1–iv63. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Thomas AA, Brennan CW, DeAngelis LM and
Omuro AM: Emerging therapies for glioblastoma. JAMA Neurol.
71:1437–1444. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cuddapah VA, Robel S, Watkins S and
Sontheimer H: A neurocentric perspective on glioma invasion. Nat
Rev Neurosci. 15:455–465. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Frisch SM and Francis H: Disruption of
epithelial cell-matrix interactions induces apoptosis. J Cell Biol.
124:619–626. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gilmore AP: Anoikis. Cell Death Differ. 12
Suppl 2:S1473–S1477. 2005. View Article : Google Scholar
|
|
6
|
Chaffer CL and Weinberg RA: A perspective
on cancer cell metastasis. Science. 331:1559–1564. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Thompson EW, Newgreen DF and Tarin D:
Carcinoma invasion and metastasis: A role for
epithelial-mesenchymal transition? Cancer Res. 65:5991–5995. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zanotti S, Gibertini S, Bragato C,
Mantegazza R, Morandi L and Mora M: Fibroblasts from the muscles of
Duchenne muscular dystrophy patients are resistant to cell
detachment apoptosis. Exp Cell Res. 317:2536–2547. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hanks SK, Ryzhova L, Shin NY and Brábek J:
Focal adhesion kinase signaling activities and their implications
in the control of cell survival and motility. Front Biosci.
8:d982–d996. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Harrison KA, Thaler J, Pfaff SL, Gu H and
Kehrl JH: Pancreas dorsal lobe agenesis and abnormal islets of
Langerhans in Hlxb9-deficient mice. Nat Genet. 23:71–75. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dalgin G, Ward AB, le Hao T, Beattie CE,
Nechiporuk A and Prince VE: Zebrafish mnx1 controls cell fate
choice in the developing endocrine pancreas. Development.
138:4597–4608. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Garcia-Barceló MM, Lui VC, So MT, Miao X,
Leon TY, Yuan ZW, Ngan ES, Ehsan T, Chung PH, Khong PL, et al: MNX1
(HLXB9) mutations in Currarino patients. J Pediatr Surg.
44:1892–1898. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Das M: MNX1: A novel prostate cancer
oncogene. Lancet Oncol. 17:e5212016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lamballe F, Klein R and Barbacid M: The
trk family of oncogenes and neurotrophin receptors. Princess
Takamatsu Symp. 22:153–170. 1991.PubMed/NCBI
|
|
15
|
Shen J and Maruyama IN: Brain-derived
neurotrophic factor receptor TrkB exists as a preformed dimer in
living cells. J Mol Signal. 7:22012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li M, Dai FR, Du XP, Yang QD, Zhang X and
Chen Y: Infusion of BDNF into the nucleus accumbens of aged rats
improves cognition and structural synaptic plasticity through
PI3K-ILK-Akt signaling. Behav Brain Res. 231:146–153. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Allen M, Bjerke M, Edlund H, Nelander S
and Westermark B: Origin of the U87MG glioma cell line: Good news
and bad news. Sci Transl Med. 8:354re32016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xiong J, Zhou LI, Lim Y, Yang M, Zhu YH,
Li ZW, Fu DL and Zhou XF: Mature brain-derived neurotrophic factor
and its receptor TrkB are upregulated in human glioma tissues.
Oncol Lett. 10:223–227. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wirtz D, Konstantopoulos K and Searson PC:
The physics of cancer: The role of physical interactions and
mechanical forces in metastasis. Nat Rev Cancer. 11:512–522. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dawson H, Grundmann S, Koelzer VH, Galván
JA, Kirsch R, Karamitopoulou E, Lugli A, Inderbitzin D and Zlobec
I: Tyrosine kinase receptor B (TrkB) expression in colorectal
cancers highlights anoikis resistance as a survival mechanism of
tumour budding cells. Histopathology. 66:715–725. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kornblith PL and Walker M: Chemotherapy
for malignant gliomas. J Neurosurg. 68:1–17. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rao JS: Molecular mechanisms of glioma
invasiveness: The role of proteases. Nat Rev Cancer. 3:489–501.
2003. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wirsching HG, Galanis E and Weller M:
Glioblastoma. Handb Clin Neurol. 134:381–397. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Furnari FB, Cloughesy TF, Cavenee WK and
Mischel PS: Heterogeneity of epidermal growth factor receptor
signalling networks in glioblastoma. Nat Rev Cancer. 15:302–310.
2015. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Reardon DA and Wen PY: Glioma in 2014:
Unravelling tumour heterogeneity-implications for therapy. Nat Rev
Clin Oncol. 12:69–70. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Black PM: Brain tumors. Part 1. N Engl J
Med. 324:1471–1476. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cancer Genome Atlas Research Network:
Comprehensive genomic characterization defines human glioblastoma
genes and core pathways. Nature. 455:1061–1068. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sawamiphak S, Seidel S, Essmann CL,
Wilkinson GA, Pitulescu ME, Acker T and Acker-Palmer A: Ephrin-B2
regulates VEGFR2 function in developmental and tumour angiogenesis.
Nature. 465:487–491. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Brennan CW, Verhaak RG, McKenna A, Campos
B, Noushmehr H, Salama SR, Zheng S, Chakravarty D, Sanborn JZ,
Berman SH, et al: The somatic genomic landscape of glioblastoma.
Cell. 155:462–477. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ross AJ, Ruiz-Perez V, Wang Y, Hagan DM,
Scherer S, Lynch SA, Lindsay S, Custard E, Belloni E, Wilson DI, et
al: A homeobox gene, HLXB9, is the major locus for dominantly
inherited sacral agenesis. Nat Genet. 20:358–361. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang Y, Wang J, Zhang L, Karatas OF, Shao
L, Zhang Y, Castro P, Creighton CJ and Ittmann M: RGS12 is a novel
tumor-suppressor gene in African American prostate cancer that
represses AKT and MNX1 expression. Cancer Res. 77:4247–4257. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang L, Wang J, Wang Y, Zhang Y, Castro
P, Shao L, Sreekumar A, Putluri N, Guha N, Deepak S, et al: MNX1 is
oncogenically upregulated in African-American prostate cancer.
Cancer Res. 76:6290–6298. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li Z, Tan F and Thiele CJ: Inactivation of
glycogen synthase kinase-3beta contributes to brain-derived
neutrophic factor/TrkB-induced resistance to chemotherapy in
neuroblastoma cells. Mol Cancer Ther. 6:3113–3121. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kermani P and Hempstead B: Brain-derived
neurotrophic factor: A newly described mediator of angiogenesis.
Trends Cardiovasc Med. 17:140–143. 2007. View Article : Google Scholar : PubMed/NCBI
|
